Table1.
Effect of microRNA expression on colorectal cancer treatment
| MicroRNA | Expression | Effect on treatment | Reference |
| * EGFR: Epidermal growth factor receptor. Arrows indicate upregulated or downregulated expression | |||
| Let-7 | Increased sensitivity to EGFR*-targeted treatment | 164-167 | |
| MiR-126 | Decreased sensitivity to capecitabine and oxaliplatin (XELOX) | 168-169 | |
| MiR-31 | Decreased sensitivity to 5-fluorouracil | 170 | |
| MiR-192/ miR-215 | Increased resistance to 5-fluorouracil | 171 | |
| MiR-148a | Poor sensitivity to oxaliplatin and oxaliplatin plus 5-fluorouracil | 172 | |
| MiR-21 | Poor sensitivity to 5-fluorouracil | 173,174 | |
| MiR-129 | Increased sensitivity to 5-fluorouracil | 175 | |
| MiR-19b | Increased response to 5-fluorouracil | 176 | |
| MiR-34a | Resistance to 5-fluorouracil | 177 | |
| MiR-143 | Increased response to 5-fluorouracil | 178 | |
| MiR-203 | Resistance to oxaliplatin | 179 |